GlassScriptPhysician profile
Latoya Elmes
NPI 1003328303
$4,582.46
in general payments reported to CMS, 2019-2025
22 companies · $56.87 in 2025
The $56.87 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,011 · 2022: $916 · 2023: $526 · 2024: $72.55 · 2025: $56.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.39 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,943.41 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $636.26 | 2021-2023 | |
| Nevro Corp. | $509.18 | 2021-2023 | Senza |
| Scilex Pharmaceuticals INC. | $233.82 | 2021-2023 | Ztlido |
| Grt US Holding, INC. | $196.46 | 2021-2022 | |
| Abbott Laboratories | $170.80 | 2021-2023 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.25 | 2021 | |
| Amgen INC. | $153.27 | 2021-2022 | |
| Medtronic, INC. | $126.48 | 2022-2023 | Kyphon Express II Kyphopak Tray, Synchromedii |
| Ibsa Pharma INC. | $74.63 | 2021-2022 | |
| Vertos Medical, INC. | $64.00 | 2022 | |
| Redhill Biopharma INC. | $44.18 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $40.75 | 2022-2023 | Seglentis |
| Hikma Pharmaceuticals USA | $36.47 | 2022 | |
| Radius Health, INC. | $32.80 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $31.15 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.79 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.71 | 2021 | |
| Biodelivery Sciences International, INC. | $21.04 | 2021 | |
| Kci USA, INC. | $19.75 | 2021 | |
| Bioventus LLC | $19.70 | 2022 | |
| Lilly USA, LLC | $19.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latoya Elmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.